FORM 10-K HEMISPHERX BIOPHARMA, INC.

Company

AIM ImmunoTech Inc.

Filed

April 3, 2001

Period of Report

December 31, 2000

Accession Number

0000946644-01-000001

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →